These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ruscogenin alleviates LPS-triggered pulmonary endothelial barrier dysfunction through targeting NMMHC IIA to modulate TLR4 signaling. Wu Y; Yu X; Wang Y; Huang Y; Tang J; Gong S; Jiang S; Xia Y; Li F; Yu B; Zhang Y; Kou J Acta Pharm Sin B; 2022 Mar; 12(3):1198-1212. PubMed ID: 35530141 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Class IIa HDACs improves endothelial barrier function in endotoxin-induced acute lung injury. Kovacs-Kasa A; Kovacs L; Cherian-Shaw M; Patel V; Meadows ML; Fulton DJ; Su Y; Verin AD J Cell Physiol; 2021 Apr; 236(4):2893-2905. PubMed ID: 32959895 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of fatty acid synthase protects obese mice from acute lung injury via ameliorating lung endothelial dysfunction. Wu Z; Zhu L; Nie X; Liu Y; Zhang X; Qi Y Respir Res; 2023 Mar; 24(1):81. PubMed ID: 36922854 [TBL] [Abstract][Full Text] [Related]
6. Endothelial Conditional Knockdown of NMMHC IIA (Nonmuscle Myosin Heavy Chain IIA) Attenuates Blood-Brain Barrier Damage During Ischemia-Reperfusion Injury. Gong S; Cao G; Li F; Chen Z; Pan X; Ma H; Zhang Y; Yu B; Kou J Stroke; 2021 Mar; 52(3):1053-1064. PubMed ID: 33588591 [TBL] [Abstract][Full Text] [Related]
7. Protective effect of adenosine receptors against lipopolysaccharide-induced acute lung injury. Gonzales JN; Gorshkov B; Varn MN; Zemskova MA; Zemskov EA; Sridhar S; Lucas R; Verin AD Am J Physiol Lung Cell Mol Physiol; 2014 Mar; 306(6):L497-507. PubMed ID: 24414256 [TBL] [Abstract][Full Text] [Related]
8. The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates LPS-induced acute lung injury by maintenance of pulmonary microvascular barrier via activating the Epac1/AKT pathway. Zhang N; Tang S; Zhang J; Pei B; Pang T; Sun G Biomed Pharmacother; 2022 Nov; 155():113704. PubMed ID: 36115114 [TBL] [Abstract][Full Text] [Related]
9. NMMHC IIA inhibition impedes tissue factor expression and venous thrombosis via Akt/GSK3β-NF-κB signalling pathways in the endothelium. Zhai K; Tang Y; Zhang Y; Li F; Wang Y; Cao Z; Yu J; Kou J; Yu B Thromb Haemost; 2015 Jul; 114(1):173-85. PubMed ID: 25881103 [TBL] [Abstract][Full Text] [Related]
10. HSPA12A improves endothelial integrity to attenuate lung injury during endotoxemia through activating ERKs and Akt-dependent signaling. Dai Y; Liu J; Zhang X; Min X; Wu J; Du S; Li T; Liu L; Ding Z Int Immunopharmacol; 2021 Oct; 99():107987. PubMed ID: 34343936 [TBL] [Abstract][Full Text] [Related]
11. Unfractionated heparin ameliorates pulmonary microvascular endothelial barrier dysfunction via microtubule stabilization in acute lung injury. Mu S; Liu Y; Jiang J; Ding R; Li X; Li X; Ma X Respir Res; 2018 Nov; 19(1):220. PubMed ID: 30442128 [TBL] [Abstract][Full Text] [Related]
12. PLD2 deficiency alleviates endothelial glycocalyx degradation in LPS-induced ARDS/ALI. Kong G; Li D; Liu X; Feng J; Ning F; Huang X; Qi B; Qu J; Wang X Biochem Biophys Res Commun; 2024 Jul; 716():150019. PubMed ID: 38703555 [TBL] [Abstract][Full Text] [Related]
13. GSK-3Beta-Dependent Activation of GEF-H1/ROCK Signaling Promotes LPS-Induced Lung Vascular Endothelial Barrier Dysfunction and Acute Lung Injury. Yi L; Huang X; Guo F; Zhou Z; Chang M; Huan J Front Cell Infect Microbiol; 2017; 7():357. PubMed ID: 28824887 [TBL] [Abstract][Full Text] [Related]
14. [Mechanism of high mobility group protein B1 in lipopolysaccharide-induced acute lung injury/acute respiratory distress syndrome]. Qu J; Feng J; Li J; Huang X; Qi B; Qian T; Wang X Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Aug; 34(8):825-830. PubMed ID: 36177925 [TBL] [Abstract][Full Text] [Related]
15. Myosin IIA Regulated Tight Junction in Oxygen Glucose-Deprived Brain Endothelial Cells Via Activation of TLR4/PI3K/Akt/JNK1/2/14-3-3ε/NF-κB/MMP9 Signal Transduction Pathway. Lv Y; Liu W; Ruan Z; Xu Z; Fu L Cell Mol Neurobiol; 2019 Mar; 39(2):301-319. PubMed ID: 30666520 [TBL] [Abstract][Full Text] [Related]
16. Small Immunomodulatory Molecules as Potential Therapeutics in Experimental Murine Models of Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS). Shah D; Das P; Acharya S; Agarwal B; Christensen DJ; Robertson SM; Bhandari V Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33806560 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of Pendrin by a small molecule reduces Lipopolysaccharide-induced acute Lung Injury. Lee EH; Shin MH; Gi M; Park J; Song D; Hyun YM; Ryu JH; Seong JK; Jeon Y; Han G; Namkung W; Park MS; Choi JY Theranostics; 2020; 10(22):9913-9922. PubMed ID: 32929324 [No Abstract] [Full Text] [Related]
18. Overexpression of FoxM1 optimizes the therapeutic effect of bone marrow mesenchymal stem cells on acute respiratory distress syndrome. Luo Y; Ge S; Chen Q; Lin S; He W; Zeng M Stem Cell Res Ther; 2023 Feb; 14(1):27. PubMed ID: 36788588 [TBL] [Abstract][Full Text] [Related]
19. APELIN-13 AMELIORATES LPS-INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION AND POST-ACUTE LUNG INJURY PULMONARY FIBROSIS BY SUPPRESSING TRANSFORMING GROWTH FACTOR-Β1 SIGNALING. Liu H; Shi Q; Tang L; Wang H; Wang D Shock; 2023 Jan; 59(1):108-117. PubMed ID: 36377383 [TBL] [Abstract][Full Text] [Related]
20. Calpain Promotes LPS-induced Lung Endothelial Barrier Dysfunction via Cleavage of Talin. Song L; Shi X; Kovacs L; Han W; John J; Barman SA; Dong Z; Lucas R; Fulton DJR; Verin AD; Su Y Am J Respir Cell Mol Biol; 2023 Dec; 69(6):678-688. PubMed ID: 37639326 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]